日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Treatment With Etirinotecan Pegol for Patients With Metastatic Breast Cancer and Brain Metastases: Final Results From the Phase 3 ATTAIN Randomized Clinical Trial

使用依替替康聚乙二醇治疗转移性乳腺癌和脑转移患者：ATTAIN 3期随机临床试验的最终结果

期刊:Jama Oncology
影响因子:20.1
doi:10.1001/jamaoncol.2022.0514
Tripathy, Debu; Tolaney, Sara M; Seidman, Andrew D; Anders, Carey K; Ibrahim, Nuhad; Rugo, Hope S; Twelves, Chris; Diéras, Véronique; Müller, Volkmar; Du, Yining; Currie, Sue L; Hoch, Ute; Tagliaferri, Mary; Hannah, Alison L; Cortés, Javier
神经科学
肿瘤
肿瘤免疫
乳腺癌
发表日期：2022
文献求助 收藏

Bempegaldesleukin plus nivolumab in first-line renal cell carcinoma: results from the PIVOT-02 study

贝培加地白介素联合纳武利尤单抗一线治疗肾细胞癌：PIVOT-02 研究结果

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2021-004419
Tannir, Nizar M; Cho, Daniel C; Diab, Adi; Sznol, Mario; Bilen, Mehmet A; Balar, Arjun V; Grignani, Giovanni; Puente, Erika; Tang, Lily; Chien, David; Hoch, Ute; Choudhury, Arkopal; Yu, Danni; Currie, Sue L; Tagliaferri, Mary A; Zalevsky, Jonathan; Siefker-Radtke, Arlene O; Hurwitz, Michael E
肿瘤
肾癌
肿瘤免疫
细胞生物学
发表日期：2022
文献求助 收藏

Bempegaldesleukin Plus Nivolumab in First-Line Metastatic Melanoma

一线转移性黑色素瘤治疗：贝培加地白介素联合纳武利尤单抗

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.21.00675
Diab, Adi; Tykodi, Scott S; Daniels, Gregory A; Maio, Michele; Curti, Brendan D; Lewis, Karl D; Jang, Sekwon; Kalinka, Ewa; Puzanov, Igor; Spira, Alexander I; Cho, Daniel C; Guan, Shanhong; Puente, Erika; Nguyen, Tuan; Hoch, Ute; Currie, Sue L; Lin, Wei; Tagliaferri, Mary A; Zalevsky, Jonathan; Sznol, Mario; Hurwitz, Michael E
黑色素瘤
发表日期：2021
文献求助 收藏

NKTR-214 immunotherapy synergizes with radiotherapy to stimulate systemic CD8(+) T cell responses capable of curing multi-focal cancer.

NKTR-214 免疫疗法与放射疗法协同作用，刺激全身 CD8(+) T 细胞反应，从而治愈多灶性癌症

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2019-000464
Walker Joshua M, Rolig Annah S, Charych Deborah H, Hoch Ute, Kasiewicz Melissa J, Rose Daniel C, McNamara Michael J, Hilgart-Martiszus Ian F, Redmond William L
细胞生物学
肿瘤免疫
发表日期：2020
文献求助 收藏

Human Abuse Potential of Oral NKTR-181 in Recreational Opioid Users: A Randomized, Double-Blind, Crossover Study

口服NKTR-181在娱乐性阿片类药物使用者中的滥用潜力：一项随机、双盲、交叉研究

期刊:Pain Medicine
影响因子:3
doi:10.1093/pm/pnz232
Ge, Xue; Henningfield, Jack E; Siddhanti, Suresh; Jobes, Janet; Lu, Lin; Xie, Sunny; Ziola, Margaret; Kelsh, Debra; Vince, Bradley; Di Fonzo, Carlo J; Tagliaferri, Mary; Zalevsky, Jonathan; Doberstein, Stephen K; Hoch, Ute; Eldon, Michael A
Human
发表日期：2020
文献求助 收藏

Integrated population pharmacokinetics of etirinotecan pegol and its four metabolites in cancer patients with solid tumors

实体瘤癌症患者体内依替替康聚乙二醇及其四种代谢物的群体药代动力学研究

期刊:Cancer Chemotherapy and Pharmacology
影响因子:2.3
doi:10.1007/s00280-018-3562-3
Sy, Sherwin K B; Chia, Yen Lin; Gordi, Toufigh; Hoch, Ute; Eldon, Michael A
肿瘤
肿瘤免疫
代谢
发表日期：2018
文献求助 收藏

Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial

乳腺癌合并脑转移病史患者的生存期延长：随机 III 期 BEACON 试验预先计划的亚组分析结果

期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-017-4304-7
Cortés, Javier; Rugo, Hope S; Awada, Ahmad; Twelves, Chris; Perez, Edith A; Im, Seock-Ah; Gómez-Pardo, Patricia; Schwartzberg, Lee S; Diéras, Veronique; Yardley, Denise A; Potter, David A; Mailliez, Audrey; Moreno-Aspitia, Alvaro; Ahn, Jin-Seok; Zhao, Carol; Hoch, Ute; Tagliaferri, Mary; Hannah, Alison L; O'Shaughnessy, Joyce
神经科学
肿瘤
肿瘤免疫
乳腺癌
发表日期：2017
文献求助 收藏

Erratum to: Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial

更正：乳腺癌合并脑转移病史患者的生存期延长：随机 III 期 BEACON 试验预先计划的亚组分析结果

期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-017-4482-3
Cortés, Javier; Rugo, Hope S; Awada, Ahmad; Twelves, Chris; Perez, Edith A; Im, Seock-Ah; Gómez-Pardo, Patricia; Schwartzberg, Lee S; Diéras, Veronique; Yardley, Denise A; Potter, David A; Mailliez, Audrey; Moreno-Aspitia, Alvaro; Ahn, Jin-Seok; Zhao, Carol; Hoch, Ute; Tagliaferri, Mary; Hannah, Alison L; O'Shaughnessy, Joyce
神经科学
肿瘤
肿瘤免疫
乳腺癌
发表日期：2017
文献求助 收藏

Etirinotecan pegol administration is associated with lower incidences of neutropenia compared to irinotecan administration

与伊立替康给药相比，依替替康聚乙二醇给药可降低中性粒细胞减少症的发生率。

期刊:Cancer Chemotherapy and Pharmacology
影响因子:2.3
doi:10.1007/s00280-016-3192-6
Sy, S Kenneth; Sweeney, Theresa D; Ji, Chunmei; Hoch, Ute; Eldon, Michael A
细胞生物学
中性粒细胞
粒细胞
发表日期：2017
文献求助 收藏

Randomized study of etirinotecan pegol versus irinotecan as second-line treatment for metastatic colorectal cancer

一项随机研究比较了依替尼康聚乙二醇与伊立替康作为转移性结直肠癌二线治疗的疗效

期刊:Cancer Chemotherapy and Pharmacology
影响因子:2.3
doi:10.1007/s00280-017-3438-y
Lenz, Heinz-Josef; Philip, Philip; Saunders, Mark; Kolevska, Tatjana; Mukherjee, Kalyan; Samuel, Leslie; Bondarde, Shailesh; Dobbs, Tracy; Tagliaferri, Mary; Hoch, Ute; Hannah, Alison L; Berkowitz, Maurice
肿瘤
肠癌
肿瘤免疫
发表日期：2017
文献求助 收藏